To evaluate the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted individuals
The visit dates for this study are a candidacy evaluation, a baseline evaluation, the Initial Activation, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years. Most of these visits will be at the same time as your clinical audiologist visits.More
Eligibility criteria are if the participant would meet the Nucleus Hybrid L24 Implant System.
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
University of Colorado Hospital
Stephen Cass, MD, MPH/MSPH
Protocol Number: 14-1927
More information available at ClinicalTrials.gov: NCT02379819
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers